Director/PDMR Shareholding

GlaxoSmithKline PLC 12 January 2007 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons The Administrators of the GlaxoSmithKline Performance Share Plan notified the Company and the under-mentioned persons on 12 January 2007 of an increase in their notional interests in Ordinary Shares at a price of £13.92 per share and Ordinary Share ADRs at a price of $52.98 per ADR following the notional re-investment of the dividend paid to shareholders on 4 January 2007. Ordinary Shares ADRs Dr JP Garnier 5,559.21 Mr J S Heslop 1,016.15 Dr M M Slaoui 340.26 Mrs C Bruck Slaoui 29.63 Mr R Bondy 2,104.41 Dr F Calhoun 673.34 Mr J Clarke 916.09 Mr M Dunoyer 599.39 Dr R Greig 440.17 Mr D Learmouth 99.49 Mr D Phelan 1,036.94 Dr D Pulman 473.37 440.17 Mr D Stout 2,131.09 Mr C Viehbacher 1,036.94 Mr A P Witty 1,933.99 The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period. This notification relates to a transaction notified in accordance with Disclosure Rules 3.1.4R(1)(a) and 3.1.4R(1)(b). S M Bicknell Company Secretary 12 January 2007 This information is provided by RNS The company news service from the London Stock Exchange

Companies

GSK (GSK)
UK 100